Literature DB >> 28965131

Efficacy of tocilizumab highlighted by FDG-PET/CT in a patient with relapsing polychondritis-associated aortitis.

Ghassan Elourimi1, Michael Soussan2, Ursula Warzocha1, Hélène Bugaud1, Robin Dhôte1, Sébastien Abad3.   

Abstract

Relapsing polychondritis (RP) is a rare systemic inflammatory disease primarily affecting the ears, nose and tracheobronchial tree cartilage, but also the cardiovascular system. Cardiovascular complications are the second cause of mortality in RP. We report the case of a woman with a corticosteroid-resistant RP-associated aortitis, who was successfully treated with tocilizumab (TCZ). The FDG-PET/CT was a useful tool for diagnosing aortitis and assessing the effect of biotherapy. We conducted a systematic literature review confirming this is the first case of rapid and sustained remission in a patient with corticosteroid-resistant RP-associated aortitis after TCZ treatment administered as a first-line immunotherapy. However, further studies are needed to confirm the beneficial effect of TCZ used in this life-threatening condition.

Entities:  

Keywords:  Aortitis; FDG-PET/CT; Relapsing polychondritis; Tocilizumab; Vasculitis

Mesh:

Substances:

Year:  2017        PMID: 28965131     DOI: 10.1007/s00296-017-3832-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  32 in total

1.  A case of relapsing polychondritis with coronary ostial stenosis and severe aortic incompetence.

Authors:  A Yung; H A Charleson; R Ullal; A Doube
Journal:  Semin Arthritis Rheum       Date:  2000-10       Impact factor: 5.532

Review 2.  Utility of fluorodeoxyglucose positron emission tomography/computed tomography for early diagnosis and evaluation of disease activity of relapsing polychondritis: a case series and literature review.

Authors:  Hiroyuki Yamashita; Hiroyuki Takahashi; Kazuo Kubota; Yo Ueda; Takashi Ozaki; Hideki Yorifuji; Ei Bannai; Ryogo Minamimoto; Miyako Morooka; Yoko Miyata; Momoko Okasaki; Yuko Takahashi; Hiroshi Kaneko; Toshikazu Kano; Akio Mimori
Journal:  Rheumatology (Oxford)       Date:  2014-03-27       Impact factor: 7.580

3.  Tocilizumab in refractory aortitis: study on 16 patients and literature review.

Authors:  Javier Loricera; Ricardo Blanco; Santos Castañeda; Alicia Humbría; Norberto Ortego-Centeno; Javier Narváez; Cristina Mata; Sheila Melchor; Elena Aurrecoechea; Jaime Calvo-Alén; Pau Lluch; Concepción Moll; Mauricio Mínguez; Gabriel Herrero-Beaumont; Beatriz Bravo; Esteban Rubio; Mercedes Freire; Enriqueta Peiró; Carmen González-Vela; Javier Rueda-Gotor; Trinitario Pina; Natalia Palmou-Fontana; Vanesa Calvo-Río; Francisco Ortiz-Sanjuán; Miguel Ángel González-Gay
Journal:  Clin Exp Rheumatol       Date:  2014-05-15       Impact factor: 4.473

4.  Sustained response to infliximab in a patient with relapsing polychondritis with aortic involvement.

Authors:  Isabelle Marie; Laure Lahaxe; Séverine Josse; Hervé Levesque
Journal:  Rheumatology (Oxford)       Date:  2009-08-03       Impact factor: 7.580

5.  Aortitis in relapsing polychondritis.

Authors:  U A Walker; S M Weiner; P Vaith; M Uhl; H H Peter
Journal:  Br J Rheumatol       Date:  1998-12

Review 6.  Sustained response to tocilizumab in a patient with relapsing polychondritis complicated by aortitis.

Authors:  Meritxell Sallés; Sonia Mínguez; Sandra Ros; Roser Tuneu; Saul Mario Gelman
Journal:  Clin Exp Rheumatol       Date:  2017-02-22       Impact factor: 4.473

7.  Refractory relapsing polychondritis treated with serial success with interleukin 6 receptor blockade.

Authors:  Zachary S Wallace; John H Stone
Journal:  J Rheumatol       Date:  2013-01       Impact factor: 4.666

Review 8.  Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors.

Authors:  Armen Yuri Gasparyan; Lilit Ayvazyan; Heather Blackmore; George D Kitas
Journal:  Rheumatol Int       Date:  2011-07-29       Impact factor: 2.631

9.  Serum level of macrophage migration inhibitory factor as a useful parameter of clinical course in patients with Wegener's granulomatosis and relapsing polychondritis.

Authors:  R Ohwatari; S Fukuda; K Iwabuchi; Y Inuyama; K Onoé; J Nishihira
Journal:  Ann Otol Rhinol Laryngol       Date:  2001-11       Impact factor: 1.547

10.  Dramatic Response to Tocilizumab Before Emergency Surgery in Severe Active Takayasu Disease.

Authors:  Jessie Risse; Damien Mandry; Nicla Settembre; Charlène Vigouroux; Marine Claudin; Georgia Tsintzila; Olivier Huttin; Sergueï Malikov; Stéphane Zuily; Denis Wahl
Journal:  Circ Cardiovasc Imaging       Date:  2016-07       Impact factor: 7.792

View more
  4 in total

Review 1.  Aortic involvement in relapsing polychondritis: case-based review.

Authors:  Mustafa Erdogan; Sinem Nihal Esatoglu; Gulen Hatemi; Vedat Hamuryudan
Journal:  Rheumatol Int       Date:  2019-11-25       Impact factor: 2.631

2.  Sudden Cardiac Death due to Coronary Artery Vasculitis in a Patient with Relapsing Polychondritis.

Authors:  Heather Bukiri; Steven M Ruhoy; Jane H Buckner
Journal:  Case Rep Rheumatol       Date:  2020-11-16

Review 3.  Mimickers of Large Vessel Giant Cell Arteritis.

Authors:  André Ramon; Hélène Greigert; Paul Ornetti; Bernard Bonnotte; Maxime Samson
Journal:  J Clin Med       Date:  2022-01-19       Impact factor: 4.241

Review 4.  Role of PET/CT in the Evaluation of Aortic Disease.

Authors:  Jahae Kim; Ho-Chun Song
Journal:  Chonnam Med J       Date:  2018-09-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.